The overall prognostic impact of SENP1 expression was – although statistically highly significant - rather small in absolute numbers.
← all excerpts
The prognostic value of SUMO1/Sentrin specific peptidase 1 (SENP1) in prostate cancer is limited to ERG-fusion positive tumors lacking PTEN deletion.
1
—
—